R&D spending in Sweden by business rose an estimated 4.2% in 2008 to SEK 87,681 million ($12,498 million) in constant prices. Within the business sector, R&D investments by producers of goods accounted for 75% of spending compared to 25% for the service sector. R&D spending by the higher education sector (excluding ALF funds) also increased, […]
HSBC estimates that $512 million in worldwide stimulus funding will go toward green projects. In 2009, 22% of this funding is expected to be spent. South Korea has committed the largest share of its economic stimulus plan, 79%, to green projects, with major programs for job creation and clean technology. The EU has pledged a […]
A new report from the European Commission’s Joint Research Center estimates that the number of genetically modified (GM) crops will reach 124 by 2015, compared to 33 in 2008, and will include GM rice and potato, which are not currently commercialized. GM cotton will account for the largest number of GM crops in 2015, with […]
Agilent disclosed few additional details in its August 17 quarterly conference call about its agreement to acquire Varian for $1.5 billion (see IBO 7/31/09, 8/15/09). The $1.5 billion deal includes the purchase of outstanding common stock, cashing out of “in the money” stock options and assumed debt. Varian shareholders will vote on the merger agreement […]
Drs. Darren E. Zinner and Eric G. Campbell of Brandeis University analyzed the results of a survey of 1,663 life science faculty at 50 US universities with medical schools conducted between September 2006 and February 2007 to examine life science research at US academic medical centers. The mean research time for respondents was 23 hours […]
Second-quarter 2009 IBO Life Science Index sales declined 4.3% to $2,336.48 million. Operating profit grew 5.9% to $404.34 million, and operating margin climbed 170 basis points to 17.3% of sales. Sales growth for a majority of companies was adversely affected by currency transactions and budget constraints. Operating profits benefited from restructuring activities. Second-quarter sales for […]
Dublin, Ireland 9/3/09—Health care products company Covidien has ceased marketing for sale its Specialty Chemicals business, which includes Mallinckrodt Baker, a provider of laboratory chemicals and reagents. The company will reclassify the business as a continuing operation within its Pharmaceuticals segment.
Cambridge, MA 9/3/09—Next-generation sequencer developer Helicos BioSciences has engaged Thomas Weisel Partners to assist in its strategic evaluation and execution of strategic alternatives. The company is currently engaged in discussions with potential partners both inside and outside the genetic sequencing market regarding strategic alternatives, including equity financing and other funding sources, such as partnerships. (For […]
Holliston, MA 9/3/09—Harvard Bioscience has acquired substantially all of the assets of Denville Scientific and assumed certain of the company’s liabilities. The purchase price is expected to be $23–$24 million, depending on Denville’s 2009 financial results. Denville is a distributor of molecular biology products, with a focus on liquid handling items. In 2008, Denville had […]
Santa Clara, CA 9/8/09—Cell Biosciences has agreed to acquire Alpha Innotech for $1.50 per share (a 70.5% premium over the September 4 price), or $17.9 million in cash, and the assumption of $2.1 million in debt. Alpha Innotech provides digital imaging systems, including gel documentation systems. Based in San Leandro, California, the company reported 2008 […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
